Evaluation of a tumor marker of pancreatic cancer. Preliminary results
Venot, J.; Vincent, D.; Clement, M.N.; Beck, C.
Presse Medicale 13(7): 440-441
1984
ISSN/ISBN: 0755-4982 PMID: 6230617 Document Number: 229867
Document emailed within 1 workday
Related Documents
Oremek, G.M.; Eigenbrodt, E.; Rädle, J.; Zeuzem, S.; Seiffert, U.B. 1997: Value of the serum levels of the tumor marker TUM2-PK in pancreatic cancer Anticancer Research 17(4b): 3031-3033Balachandra, K.; Laisupasin, P.; Dhepakson, P.; Warachit, J.; Jantraraksri, U.; Issaragrisil, S.; Yang, X.-L.; Hus, G.-X. 2003: Preliminary clinical evaluation of a protein chip for tumor marker serodiagnosis of various cancers Asian Pacific Journal of Allergy and Immunology 21(3): 171-178
Kikuchi, K.; Uematsu, Y.; Takada, Y.; Kurihara, E.; Suito, T.; Fujisaki, M.; Takahashi, R.; Tamura, T. 1987: Evaluation of tumor marker CA15-3 in breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 14(11): 3095-3100
Ubukata, H.; Katano, M.; Motohashi, G.; Kasuga, T.; Takemura, A.; Tabuchi, T.; Tabuchi, T. 2003: Evaluation of CA72-4 as a tumor marker in patients with gastric cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 30(11): 1821-1824
Yonei, T.; Ohnoshi, T.; Hiraki, S.; Yamashita, H.; Ishii, J.; Egawa, T.; Kozuka, A.; Moritaka, T.; Uji, H.; Yoshida, M. 1988: Clinical evaluation of serum neuron-specific enolase as a tumor marker in lung cancer Nihon Kyobu Shikkan Gakkai Zasshi 26(2): 139-144
Yokomatsu, H.; Satake, K. 1992: Effect of lipid A on the production of tumor necrosis factor (TNF) and antitumor activity against pancreatic cancer cells: preliminary report Nihon Geka Gakkai Zasshi 93(7): 771
Kobayashi, N.; Fujita, K.; Fujisawa, T.; Takahashi, H.; Yoneda, M.; Abe, Y.; Inamori, M.; Kirikoshi, H.; Kubota, K.; Saito, S.; Nakajima, A. 2008: Which is the best monitoring study (tumor marker, computed tomography or 18F-fluoro-2-deoxy-D-glucose positron emission tomography) to evaluate efficacy of chemotherapy on unresectable pancreatic cancer ? Gan to Kagaku Ryoho. Cancer and ChemoTherapy 35(1): 65-70
Yang, X.-Q.; Yan, L.; Chen, C.; Hou, J.-X.; Li, Y. 2009: Application of C12 multi-tumor marker protein chip in the diagnosis of gastrointestinal cancer: results of 329 surgical patients and suggestions for improvement Hepato-Gastroenterology 56(94-95): 1388-1394
Hilmy, A.M.; Kandeel, K.M.; Selim, N.M. 1984: Pancreatic amylase as a tumour marker for pancreatic cancer Archiv für Geschwulstforschung 54(6): 475-482
Bébarová, L.; Skalický, P.; Srovnal, J.; Prokopová, A.; Zapletalová, J.; Hajdúch, M.; Loveček, M. 2018: The effect of circulating tumor cells on the survival of patients with pancreatic cancer 5-year results Rozhledy v chirurgii: mesicnik Ceskoslovenske chirurgicke spolecnosti 97(2): 94-98
Julvez, J.; Vaillant, J.Y. 1985: Cancer on the Island of Réunion: results of a survey preliminary to the creation of a tumor registry Revue d'Epidemiologie et de Sante Publique 33(1): 39-42
Ajihara, T.; Shimizu, K.; Shiratori, K. 2015: Tumor marker of pancreatic tumor Nihon Rinsho. Japanese Journal of Clinical Medicine 73(Suppl 3): 45-49
Zhyl'chuk, V.I.; Alistratov, O.V.; Vorontsova, A.L. 1998: The evaluation of the efficacy of adjuvant laferon therapy in the combined treatment of patients with ovarian cancer based on the monitoring of the tumor marker Ca-125 in the blood serum Likars'ka Sprava 2: 137-139
Chiewvit, S.; Phasuk, S.; Surapako, S.; Juiklom, W.; Chiewvit, P. 2010: Screening may not be accurate word to represent the cases submitted to PET/CT evaluation for primary tumor in a patient who has abnormal serum tumor marker Journal of the Medical Association of Thailand 93(3): 330-336
Kos, T.; Aksoy, S.; Sendur, M.A.N.; Arik, Z.; Civelek, B.; Kandemir, N.; Ozdemir, N.Y.; Zengin, N.; Altundag, K. 2013: Variations in tumor marker levels in metastatic breast cancer patients according to tumor subtypes Journal of BUON: Official Journal of the Balkan Union of Oncology 18(3): 608-613
Hardt, P.D.; Ngoumou, B.K.; Rupp, J.; Schnell-Kretschmer, H.; Kloer, H.U. 2000: Tumor M2-pyruvate kinase: a promising tumor marker in the diagnosis of gastro-intestinal cancer Anticancer Research 20(6d): 4965-4968
Nakayama, T.; Morishita, T.; Kamiya, T. 2003: K-ras as a genetic marker in pancreatic cancer Acta Gastroenterologica Latinoamericana 33(1): 43-46
Kapustin, V.V.; Gromov, A.I.; Koshurnikov, D.S. 2012: Comparative evaluation of the efficiency of different magnetic resonance imaging procedures in the recognition of local recurrence of prostate cancer: preliminary results Vestnik Rentgenologii i Radiologii 5: 48-51
Kimura, E.; Murae, M.; Koga, R.; Odawara, Y.; Nakabayashi, Y.; Yokoyama, K.; Nakata, H.; Totake, T.; Ochiai, K.; Yasuda, M. 1984: Clinical significance of new tumor marker CA 125 in gynecological cancer--particularly usefulness in diagnosis of ovarian cancer Nihon Sanka Fujinka Gakkai Zasshi 36(11): 2121-2128
Ariyama, J.; Ikenobu, H.; Kurozawa, A.; Kawai, S.; Shirota, K. 1977: Upper abdominal pain and a loss of weight and appetite (radiography of the pancreatic duct and abdominal angiography): (tumor of the pancreatic head--a tumor mainly of the uncinate process and multiple pancreatic cyst) Nihon Rinsho. Japanese Journal of Clinical Medicine 35(Suppl 2): 3106-3107; 3470-3471